Related Experiment Video

Updated: May 25, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Interaction networks of hepatitis C virus NS4B: implications for antiviral therapy

Shanshan Li1, Xilan Yu, Yunli Guo

  • 1Department of Plant Pathology and Microbiology, Iowa State University, Ames, IA, USA.

Cellular Microbiology
|February 15, 2012
PubMed

Insights

Hepatitis C virus non-structural protein 4B (NS4B) is crucial for viral replication. Understanding its interactions with host factors reveals new therapeutic targets for Hepatitis C virus (HCV) infection.

Area of Science:

  • Virology
  • Molecular Biology
  • Immunology

Background:

  • Hepatitis C virus (HCV) infects over 170 million people globally.
  • HCV relies on viral-host interactions for replication and survival.
  • HCV non-structural protein 4B (NS4B) is vital for viral propagation and pathogenesis.

Purpose of the Study:

  • To review current knowledge on NS4B interaction networks with host factors.
  • To elucidate the regulatory mechanisms of NS4B-host interactions.
  • To identify potential therapeutic targets for HCV.

Main Methods:

  • Literature review of scientific publications.
  • Analysis of reported NS4B-host factor interactions.
  • Examination of regulatory pathways involving NS4B.

Main Results:

  • NS4B engages in complex interactions with numerous host factors.
  • These interactions are essential for multiple stages of the HCV life cycle.
  • NS4B plays a significant role in modulating host cell functions to favor viral replication.

Conclusions:

  • NS4B is a key mediator of Hepatitis C virus-host interactions.
  • Understanding these networks advances knowledge of the HCV life cycle.
  • NS4B and its interaction partners represent promising targets for novel anti-HCV therapies.

More Related Videos

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...